Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar - VIA ZOOM

NANCY BONINI, UNIVERSITY OF PENNSYLVANIA

The Bonini lab specializes in using the genetically tractable model organism, Drosophila, as a tool to understand the molecular basis of disease and disorder of the brain, with a particular focus on degenerative processes including ALS/FTD, TBI and aging. They implement cutting-edge genetic, molecular and cellular approaches to develop and characterize models of these processes to study their molecular basis, with an emphasis on potential translatability to clinical improvement.

Please note:

This and other Stanford Bio-X seminars and events will be conducted virtually over Zoom. Please join the meeting with the information on the webpage and mute your computer's audio if needed.

Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar

YI ZHANG, HARVARD UNIVERSITY

The neuronal heterogeneity and complex connections of the brain reward system prevented a deeper understanding of the drug addiction mechanisms. The study Dr. Zhang will present provides a broadly applicable strategy for understanding the molecular, cellular and circuitry mechanism of drug addiction and other psychiatric diseases.

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Pre-Seminar

XIAOKE CHEN, DEPARTMENT OF BIOLOGY

Attend Dr. Chen's pre-seminar presentation to learn more about Dr. Yi Zhang's seminar, "Understanding drug addiction by classification and characterization of cell types of the brain reward system", to be held Thursday, March 5th.

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Pre-Seminar

OVIJIT CHAUDHURI, DEPARTMENT OF MECHANICAL ENGINEERING

Attend Dr. Chaudhuri's pre-seminar presentation to learn more about Dr. Kenneth Yamada's seminar, "Dynamics of 3D Cell Migration and Organogenesis", to be held Thursday, February 20th.

Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar

KENNETH YAMADA, NIH NIDCR

Dr. Kenneth Yamada's group's overall research goals are to discover novel mechanisms and regulators of cell interactions with the extracellular matrix and their roles in craniofacial development and disease pathogenesis. The mechanobiology underlying cell migration, spatially regulated deposition of matrix, and sculpting of initially unorganized cells into complex branched organs are being characterized and experimentally manipulated using mouse embryonic organ culture and 3D human cell and spheroid models. These studies provide unexpected new insights into the dynamic forces and specific molecules involved in 3D cell migration and the remodeling of epithelial cells into 3D embryonic tissue architecture.

Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar

BARBARA ENGELHARDT, PRINCETON UNIVERSITY

The Engelhardt Group develops statistical models and methods for high-dimensional genomic data. In particular, we study human genetic variation and its impact on genomic regulation, including gene expression and splicing, with the goal of identifying mechanisms of human disorders and diseases.

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Pre-Seminar

JULIA SALZMAN, DEPARTMENTS OF BIOCHEMISTRY AND BIOMEDICAL DATA SCIENCE

Attend Dr. Salzman's pre-seminar presentation to learn more about Dr. Barbara Engelhardt's seminar, "Understanding How Environment Influences Cells through Paired Images and Gene Expression Data", to be held Thursday, January 16th.

Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar

RICHARD LIEBER, NORTHWESTERN UNIVERSITY

Dr. Lieber’s work is characterized by its interdisciplinary nature—an approach that is relevant to those who study biomechanics and Orthopaedic Surgery. He has also pioneered studies of human muscle during hand surgery and in conditions of muscle contracture due to cerebral palsy.

Stanford Bio-X Frontiers in Interdisciplinary Biosciences Pre-Seminar

JAMES SPUDICH, DEPARTMENT OF BIOCHEMISTRY

Attend Dr. Spudich's pre-seminar presentation to learn more about Dr. Richard Lieber's seminar, "Intraoperative and Laboratory Studies of Human Muscle Contractures", to be held Thursday, November 14th.

Stanford bio-X Frontiers in Interdisciplinary Biosciences Seminar

TATIANA SEGURA, DUKE UNIVERSITY

Dr. Tatiana Segura's laboratory is interested designing therapies to treat stroke related disability, which are administered weeks to months after stroke. Their approach is to inject hydrogel biomaterial scaffolds into the stroke lesion that can remove the cytotoxic environment and allow pro-repair mechanisms to evolve. In this talk, Dr. Segura will focus on our efforts to design hyaluronic acid microporous annealed particle (HA-MAP) hydrogels to treat stroke related tissue loss.